1Final year B.D.S.,
2Senior Lecturer,
3Professor And Head,
4Reader,
5Reader,
6Senior Lecturer,
7Senior Lecturer,
Candida-associated denture stomatitis is characterized by generalized inflammation of the palatal mucosa covered by a denture. The aim of this study was to evaluate effectiveness of topical 1% clotrimazole and 1% chlorhexidine digluconate in management of denture stomatitis patients.
This study was a randomised clinical trial conducted on 30 denture stomatitis patients in the age range of 40–70 years who were divided into two groups. Patients in Group 1 (n=15) were treated with topical clotrimazole (1% paste, thrice daily application) whereas those in Group 2 (n=15) were treated with topical chlorhexidine digluconate (1% gel, thrice daily application). The clinical efficacy of treatment was evaluated by recording the mean scores of signs and symptoms and clinical response to treatment of denture stomatitis after 21 days.
At the follow up visit, patients in Group 1 showed; significant reduction in soreness and inflammation while group 2 showed significant reductions in soreness only. Clinical response to treatment in group 1 was graded as 53.3% cure, 33.3% improvement and 13.3% failure, whereas in Group 2 it was 26.6% cure, 46.6% improvement 26.6% failure. On intergroup comparison, there was no statistical significant difference observed between both the treatment groups.
Considering the effectiveness of treatment modalities used in this study, 1% clotrimazole application was found to be relatively more effective than 1% chlorhexidine application in controlling signs and symptoms associated with denture stomatitis.
Denture stomatitis, Candida albicans, clotrimazole, chlorhexidine digluconate